RAPID ACCESS TO PREVENTIVE INTERVENTION DEVELOPMENT (RAPID) PROGRAM
Projects and Investigators
FY 2001 Projects
Dartmouth Medical School
Objective:
Bulk synthesis of the new triterpenoids, 2-Carboxy-DDO methyl ester and its homolog, 2-Carboxy-DDO ethyl ester.
Program Description:
Investigators will conduct preclinical development of the new triterpenoids, 2-Carboxy-DDO methyl ester and its homolog, 2-Carboxy-DDO ethyl ester. These 2 new triterpenoids were synthesized to obviate some of the in vivo limitations of their predecessors, namely poor pharmacokinetic profile. Preliminary data suggest that these compounds have numerous activities in cell culture (including inhibition of inducible nitric oxide synthetase and cyclooxygenase-2 and binding to PPAR-g receptor) and in vivo that are relevant to prevention of human cancer. RAPID support will include:
- bulk synthesis of these compounds.
Contact Information:
Michael B. Sporn
Dartmouth Medical School
Dartmouth, NH
Tel: 603-650-6557
Fax: 603-650-1129
e-mail: Micahel.B.Sporn@Dartmouth.edu
View investigator's other projects